Immunohistochemical analysis revealed that immunoreactivities for DNMT1 were increased in CCA compared with normal tissues (Fig. 9), suggesting that upregulation of DNMT1 results in the development of CCA and that inhibition of DNMT1 is effective therapy against it. Here, DNMT1 is linked to cholangiocarcinoma.